Security key
48669G105
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)
CUSIP: 48669G105
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / American Depositary Shares
- Shares outstanding
- 11,425,388
- Total 13F shares
- 536,161
- Share change
- +44,100
- Total reported value
- $4,344,316
- Put/Call ratio
- 65%
- Price per share
- $9.87
- Number of holders
- 12
- Value change
- +$396,634
- Number of buys
- 6
- Number of sells
- 5
Report period
Q2 2021
Institutions
12
Top holders
10
KZIA full security history
Newer quarter: Q3 2021
Previous quarter: Q1 2021
KAZIA THERAPEUTICS LTD SEC filings
KAZIA THERAPEUTICS LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48669G105
Recent filing periods:
Top shareholders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY |
13F
|
Company |
2%
|
230,801
|
$2,862,000 | — | 31 Mar 2021 | |
| Transform Wealth, LLC |
13F
|
Company |
0.93%
|
106,245
|
$129,000 | — | 31 Mar 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.35%
|
39,616
|
$491,000 | — | 31 Mar 2021 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.25%
|
28,020
|
$347,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.21%
|
24,310
|
$301,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
22,840
|
$283,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.1%
|
11,600
|
$144,000 | — | 31 Mar 2021 | |
| Total Clarity Wealth Management, Inc. |
13F
|
Company |
0.02%
|
1,790
|
$22,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,616
|
$20,000 | — | 31 Mar 2021 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
100
|
$1,240 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
91
|
$1,000 | — | 31 Mar 2021 | |
| RBC Europe Ltd |
13F
|
Company |
0%
|
32
|
$397 | — | 31 Mar 2021 |
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) as of Q2 2021
As of 30 Jun 2021,
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
536,161 shares.
The largest 10 holders included
MORGAN STANLEY, Transform Wealth, LLC, RENAISSANCE TECHNOLOGIES LLC, SG Americas Securities, LLC, TRUIST FINANCIAL CORP, ACT Capital Management, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, SIMPLEX TRADING, LLC, and Steward Partners Investment Advisory, LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
12
Q2 2021 holders
12
Holder diff
0
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.